Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.55+3.74 (+1.22%)
Close on Nov 3, 2026Market cap $119.12BP/E 33.1Yield –
Stryker Neuro Cranial by Year
Neuro Cranial — Constant Currency Growth YoY (Annual, %) (%)
Stryker Neuro Cranial: 15.9% in FY2025, up 1.8 pts from a year earlier.
Latest, FY2025
15.9%
Period ended Dec 31, 2025
Change on a year earlier
+1.8 pts
14.1% in FY2024
History
2 years
Since FY2024
Sources
1
0000310764-26-000041|syk-20260626_d2.htm
Where the FY2025 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuro Cranial — Constant Currency Growth YoY (Annual, %) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.9% | +1.8 pts | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2024 | Dec 31, 2024 | 14.1% | – | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
Cite this data
StockData. (2026). Stryker Neuro Cranial (%), annual FY2024–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/sub-neuro-cranial-cc-ann
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?